Publications by authors named "Henry Bone"

Claim this Profile
L
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
Nelson B Watts, John P Bilezikian, Henry G Bone, Bart L Clarke, Douglas Denham

J Endocr Soc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
Socrates Papapoulos, Henry Bone, Felicia Cosman, David W Dempster, Michael R McClung

J Bone Miner Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.
Paul D Miller, John P Bilezikian, Lorraine A Fitzpatrick, Bruce Mitlak, Eugene V McCloskey, Henry G Bone

Curr Med Res Opin· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
Michael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, Henry Bone, Bente Langdahl

Lancet Diabetes Endocrinol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
Michael Mannstadt, Bart L Clarke, John P Bilezikian, Henry Bone, Douglas Denham

J Clin Endocrinol Metab· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.
Michael R McClung, Jacques P Brown, Adolfo Diez-Perez, Heinrich Resch, John Caminis, Henry G Bone

J Bone Miner Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
Henry G Bone, Felicia Cosman, Paul D Miller, Gregory C Williams, Gary Hattersley

J Clin Endocrinol Metab· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab treatment in postmenopausal women with osteoporosis - Authors' reply.
Henry G Bone, Rachel B Wagman, Nicola Pannacciulli, Socrates Papapoulos

Lancet Diabetes Endocrinol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension.
Nelson B Watts, Jacques P Brown, Socrates Papapoulos, E Michael Lewiecki, David L Kendler, Henry G Bone

J Bone Miner Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Henry G Bone, Rachel B Wagman, Maria L Brandi, Jacques P Brown, Roland Chapurlat

Lancet Diabetes Endocrinol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study.
Jonathan D Adachi, Henry G Bone, Nadia S Daizadeh, Paula Dakin, Socrates Papapoulos

BMC Musculoskelet Disord· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypocalcaemia in patients with metastatic bone disease treated with denosumab.
Jean-Jacques Body, Henry G Bone, Richard H de Boer, Alison Stopeck, Catherine Van Poznak

Eur J Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementation.
Joseph R Tucci, Henry G Bone, Guoqin Su, Monique Tan, Zafer E Ozturk

Ther Adv Endocrinol Metab· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter by Ralston et al.
Frederick R Singer, Henry G Bone, David J Hosking, Kenneth W Lyles, Ian R Reid

J Clin Endocrinol Metab· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of estrogen depletion and drug treatment on collagen microstructure: implications.
Joseph M Wallace, Henry G Bone

Bonekey Rep· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.
Aliya Khan, John Bilezikian, Henry Bone, Andrey Gurevich, Peter Lakatos

Eur J Endocrinol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter.
Frederick R Singer, Henry G Bone, David J Hoskings, Kenneth W Lyles, Ian R Reid

J Clin Endocrinol Metab· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
Bente L Langdahl, Christence Stubbe Teglbjærg, Pei-Ran Ho, Roland Chapurlat, Edward Czerwinski, Henry G Bone

J Clin Endocrinol Metab· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the letter by Asik M., et al.
Frederick R Singer, Henry G Bone, David J Hosking, Kenneth W Lyles, Mohammad Hassan Murad

J Clin Endocrinol Metab· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paget's disease of bone: an endocrine society clinical practice guideline.
Frederick R Singer, Henry G Bone, David J Hosking, Kenneth W Lyles, Mohammad Hassan Murad

J Clin Endocrinol Metab· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab in postmenopausal women with low bone mineral density.
Michael R McClung, Andreas Grauer, Steven Boonen, Michael A Bolognese, Jacques P Brown, Henry G Bone

N Engl J Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
Henry G Bone, Robert Lindsay, Michael R McClung, Alfonso T Perez, Marsha G Raanan

J Clin Endocrinol Metab· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.
Henry G Bone, Roland Chapurlat, Maria-Luisa Brandi, Jacques P Brown, Edward Czerwinski

J Clin Endocrinol Metab· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.
Lee L Lanza, Lisa J McQuay, Kenneth J Rothman, Henry G Bone, Andrew M Kaunitz

J Fam Plann Reprod Health Care· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.
Chris Recknor, Edward Czerwinski, Henry G Bone, Sydney L Bonnick, Neil Binkley

Obstet Gynecol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis